Annual Total Liabilities
$75.50 M
+$26.63 M+54.49%
December 31, 2023
Summary
- As of February 8, 2025, SPRO annual total liabilities is $75.50 million, with the most recent change of +$26.63 million (+54.49%) on December 31, 2023.
- During the last 3 years, SPRO annual total liabilities has risen by +$54.09 million (+252.60%).
- SPRO annual total liabilities is now -8.80% below its all-time high of $82.78 million, reached on December 31, 2021.
Performance
SPRO Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$69.65 M
+$273.00 K+0.39%
September 30, 2024
Summary
- As of February 8, 2025, SPRO quarterly total liabilities is $69.65 million, with the most recent change of +$273.00 thousand (+0.39%) on September 30, 2024.
- Over the past year, SPRO quarterly total liabilities has dropped by -$5.84 million (-7.74%).
- SPRO quarterly total liabilities is now -16.44% below its all-time high of $83.36 million, reached on March 31, 2022.
Performance
SPRO Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
SPRO Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +54.5% | -7.7% |
| 3 y3 years | +252.6% | -7.7% |
| 5 y5 years | +474.1% | -7.7% |
SPRO Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -8.8% | +54.5% | -16.4% | +151.4% |
| 5 y | 5-year | -8.8% | +252.6% | -16.4% | +225.3% |
| alltime | all time | -8.8% | +918.7% | -16.4% | +1030.6% |
Spero Therapeutics Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $69.65 M(+0.4%) |
| Jun 2024 | - | $69.38 M(-2.9%) |
| Mar 2024 | - | $71.45 M(-5.4%) |
| Dec 2023 | $75.50 M(+54.5%) | $75.50 M(+41.4%) |
| Sep 2023 | - | $53.40 M(+21.1%) |
| Jun 2023 | - | $44.10 M(-7.6%) |
| Mar 2023 | - | $47.71 M(-2.4%) |
| Dec 2022 | $48.87 M(-41.0%) | $48.87 M(+52.8%) |
| Sep 2022 | - | $31.99 M(+15.5%) |
| Jun 2022 | - | $27.70 M(-66.8%) |
| Mar 2022 | - | $83.36 M(+0.7%) |
| Dec 2021 | $82.78 M(+286.6%) | $82.78 M(+152.4%) |
| Sep 2021 | - | $32.80 M(+11.8%) |
| Jun 2021 | - | $29.34 M(+19.3%) |
| Mar 2021 | - | $24.59 M(+14.9%) |
| Dec 2020 | $21.41 M | $21.41 M(-11.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2020 | - | $24.25 M(+1.8%) |
| Jun 2020 | - | $23.83 M(-13.2%) |
| Mar 2020 | - | $27.47 M(-12.9%) |
| Dec 2019 | $31.53 M(+139.7%) | $31.53 M(+61.9%) |
| Sep 2019 | - | $19.48 M(+51.9%) |
| Jun 2019 | - | $12.82 M(+13.2%) |
| Mar 2019 | - | $11.32 M(-13.9%) |
| Dec 2018 | $13.15 M(+54.3%) | $13.15 M(+24.4%) |
| Sep 2018 | - | $10.57 M(+52.6%) |
| Jun 2018 | - | $6.92 M(+12.4%) |
| Mar 2018 | - | $6.16 M(-27.7%) |
| Dec 2017 | $8.52 M(+15.0%) | $8.52 M(+17.2%) |
| Sep 2017 | - | $7.27 M(+6.3%) |
| Jun 2017 | - | $6.84 M(-7.7%) |
| Dec 2016 | $7.41 M(-0.3%) | $7.41 M |
| Dec 2015 | $7.43 M | - |
FAQ
- What is Spero Therapeutics annual total liabilities?
- What is the all time high annual total liabilities for Spero Therapeutics?
- What is Spero Therapeutics annual total liabilities year-on-year change?
- What is Spero Therapeutics quarterly total liabilities?
- What is the all time high quarterly total liabilities for Spero Therapeutics?
- What is Spero Therapeutics quarterly total liabilities year-on-year change?
What is Spero Therapeutics annual total liabilities?
The current annual total liabilities of SPRO is $75.50 M
What is the all time high annual total liabilities for Spero Therapeutics?
Spero Therapeutics all-time high annual total liabilities is $82.78 M
What is Spero Therapeutics annual total liabilities year-on-year change?
Over the past year, SPRO annual total liabilities has changed by +$26.63 M (+54.49%)
What is Spero Therapeutics quarterly total liabilities?
The current quarterly total liabilities of SPRO is $69.65 M
What is the all time high quarterly total liabilities for Spero Therapeutics?
Spero Therapeutics all-time high quarterly total liabilities is $83.36 M
What is Spero Therapeutics quarterly total liabilities year-on-year change?
Over the past year, SPRO quarterly total liabilities has changed by -$5.84 M (-7.74%)